Twin Tree Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-500
Closed -$5.04K 1879
2025
Q1
$5.04K Sell
500
-600
-55% -$6.49K ﹤0.01% 1504
2024
Q4
$13K Sell
1,100
-120,000
-99% -$1.42M ﹤0.01% 1488
2024
Q3
$1.4M Buy
121,100
+6,300
+5% +$71.7K ﹤0.01% 1191
2024
Q2
$1.21M Buy
+114,800
New +$1.26M ﹤0.01% 1030
2024
Q1
Sell
-483,900
Closed -$5.43M 1564
2023
Q4
$5.43M Buy
+483,900
New +$4.72M 0.01% 850

Other funds holding ROIV

Twin Tree Management's ROIV Position: Q1 2025 in Review

Twin Tree Management sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 48 shares — an estimated $519 sold.

Twin Tree Management first reported a position in ROIV in Q4 2023 and held it in 4 quarters. The position peaked at $826K in Q2 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Twin Tree Management reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Twin Tree Management sold 48 Roivant Sciences shares in Q1 2025, an estimated $519.
  • Twin Tree Management first reported a position in Roivant Sciences in Q4 2023 and held it in 4 quarters.
  • Twin Tree Management's Roivant Sciences position peaked at $826K in Q2 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Twin Tree Management's 13F filing for Q1 2025, filed 15 May 2025.